nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT2B4—pericardium—thymus cancer	0.111	0.504	CbGeAlD
Morphine—Hypogonadism—Octreotide—thymus cancer	0.0801	0.103	CcSEcCtD
Morphine—Breast feeding—Octreotide—thymus cancer	0.031	0.0398	CcSEcCtD
Morphine—Loss of libido—Octreotide—thymus cancer	0.0235	0.0301	CcSEcCtD
Morphine—Rectal disorder—Octreotide—thymus cancer	0.0221	0.0284	CcSEcCtD
Morphine—Appetite absent—Octreotide—thymus cancer	0.0218	0.028	CcSEcCtD
Morphine—Anorectal disorder—Octreotide—thymus cancer	0.0206	0.0265	CcSEcCtD
Morphine—OPRL1—hematopoietic system—thymus cancer	0.0203	0.0919	CbGeAlD
Morphine—Intestinal obstruction—Octreotide—thymus cancer	0.0159	0.0204	CcSEcCtD
Morphine—Neuralgia—Octreotide—thymus cancer	0.0156	0.02	CcSEcCtD
Morphine—UGT2B4—cardiac atrium—thymus cancer	0.0147	0.0666	CbGeAlD
Morphine—OPRL1—lymphoid tissue—thymus cancer	0.0143	0.0647	CbGeAlD
Morphine—Injection site pain—Octreotide—thymus cancer	0.0133	0.017	CcSEcCtD
Morphine—Amenorrhoea—Octreotide—thymus cancer	0.0123	0.0158	CcSEcCtD
Morphine—Drug interaction—Octreotide—thymus cancer	0.0117	0.015	CcSEcCtD
Morphine—UGT2B4—lung—thymus cancer	0.0112	0.0509	CbGeAlD
Morphine—Muscle twitching—Octreotide—thymus cancer	0.011	0.0142	CcSEcCtD
Morphine—Wheezing—Octreotide—thymus cancer	0.0105	0.0135	CcSEcCtD
Morphine—Bladder pain—Octreotide—thymus cancer	0.0098	0.0126	CcSEcCtD
Morphine—Gynaecomastia—Octreotide—thymus cancer	0.0097	0.0124	CcSEcCtD
Morphine—Hyperkinesia—Octreotide—thymus cancer	0.00945	0.0121	CcSEcCtD
Morphine—Phlebitis—Octreotide—thymus cancer	0.00913	0.0117	CcSEcCtD
Morphine—Sleep disorder—Octreotide—thymus cancer	0.00909	0.0117	CcSEcCtD
Morphine—UGT1A1—hematopoietic system—thymus cancer	0.00906	0.0411	CbGeAlD
Morphine—Polyuria—Octreotide—thymus cancer	0.00896	0.0115	CcSEcCtD
Morphine—Gastroenteritis—Octreotide—thymus cancer	0.00888	0.0114	CcSEcCtD
Morphine—Injury—Octreotide—thymus cancer	0.00856	0.011	CcSEcCtD
Morphine—Amnesia—Octreotide—thymus cancer	0.00838	0.0107	CcSEcCtD
Morphine—Visual disturbance—Octreotide—thymus cancer	0.0083	0.0107	CcSEcCtD
Morphine—Anaphylactoid reaction—Octreotide—thymus cancer	0.00813	0.0104	CcSEcCtD
Morphine—OPRL1—lymph node—thymus cancer	0.00806	0.0365	CbGeAlD
Morphine—Osteoarthritis—Octreotide—thymus cancer	0.00787	0.0101	CcSEcCtD
Morphine—Psychotic disorder—Octreotide—thymus cancer	0.00769	0.00986	CcSEcCtD
Morphine—Dehydration—Octreotide—thymus cancer	0.00732	0.00939	CcSEcCtD
Morphine—Dry skin—Octreotide—thymus cancer	0.00721	0.00926	CcSEcCtD
Morphine—Abdominal pain upper—Octreotide—thymus cancer	0.00719	0.00922	CcSEcCtD
Morphine—OPRM1—hematopoietic system—thymus cancer	0.00713	0.0323	CbGeAlD
Morphine—Cramp muscle—Octreotide—thymus cancer	0.00709	0.00909	CcSEcCtD
Morphine—Nasopharyngitis—Octreotide—thymus cancer	0.00704	0.00903	CcSEcCtD
Morphine—Abdominal distension—Octreotide—thymus cancer	0.00685	0.00879	CcSEcCtD
Morphine—Influenza—Octreotide—thymus cancer	0.0068	0.00873	CcSEcCtD
Morphine—Bronchospasm—Octreotide—thymus cancer	0.00669	0.00858	CcSEcCtD
Morphine—Sweating increased—Octreotide—thymus cancer	0.00663	0.0085	CcSEcCtD
Morphine—Dysuria—Octreotide—thymus cancer	0.00636	0.00816	CcSEcCtD
Morphine—Weight decreased—Octreotide—thymus cancer	0.00615	0.0079	CcSEcCtD
Morphine—Hyperglycaemia—Octreotide—thymus cancer	0.00614	0.00787	CcSEcCtD
Morphine—Drowsiness—Octreotide—thymus cancer	0.00606	0.00778	CcSEcCtD
Morphine—Urinary tract infection—Octreotide—thymus cancer	0.00589	0.00756	CcSEcCtD
Morphine—Conjunctivitis—Octreotide—thymus cancer	0.00589	0.00756	CcSEcCtD
Morphine—Hepatobiliary disease—Octreotide—thymus cancer	0.00574	0.00736	CcSEcCtD
Morphine—Bradycardia—Octreotide—thymus cancer	0.00554	0.00711	CcSEcCtD
Morphine—Rhinitis—Octreotide—thymus cancer	0.00546	0.007	CcSEcCtD
Morphine—Hepatitis—Octreotide—thymus cancer	0.00544	0.00699	CcSEcCtD
Morphine—Hypoaesthesia—Octreotide—thymus cancer	0.00542	0.00695	CcSEcCtD
Morphine—Oedema peripheral—Octreotide—thymus cancer	0.00536	0.00688	CcSEcCtD
Morphine—Visual impairment—Octreotide—thymus cancer	0.00525	0.00673	CcSEcCtD
Morphine—Flushing—Octreotide—thymus cancer	0.00505	0.00648	CcSEcCtD
Morphine—Mental disorder—Octreotide—thymus cancer	0.00477	0.00612	CcSEcCtD
Morphine—Malnutrition—Octreotide—thymus cancer	0.00474	0.00608	CcSEcCtD
Morphine—Erythema—Octreotide—thymus cancer	0.00474	0.00608	CcSEcCtD
Morphine—Flatulence—Octreotide—thymus cancer	0.00467	0.00599	CcSEcCtD
Morphine—Tension—Octreotide—thymus cancer	0.00465	0.00597	CcSEcCtD
Morphine—Nervousness—Octreotide—thymus cancer	0.0046	0.00591	CcSEcCtD
Morphine—Back pain—Octreotide—thymus cancer	0.00458	0.00588	CcSEcCtD
Morphine—Muscle spasms—Octreotide—thymus cancer	0.00456	0.00585	CcSEcCtD
Morphine—Vision blurred—Octreotide—thymus cancer	0.00447	0.00573	CcSEcCtD
Morphine—Tremor—Octreotide—thymus cancer	0.00444	0.0057	CcSEcCtD
Morphine—Ill-defined disorder—Octreotide—thymus cancer	0.0044	0.00564	CcSEcCtD
Morphine—Anaemia—Octreotide—thymus cancer	0.00438	0.00562	CcSEcCtD
Morphine—Agitation—Octreotide—thymus cancer	0.00436	0.00559	CcSEcCtD
Morphine—CYP2C8—hematopoietic system—thymus cancer	0.00429	0.0194	CbGeAlD
Morphine—Malaise—Octreotide—thymus cancer	0.00427	0.00548	CcSEcCtD
Morphine—Vertigo—Octreotide—thymus cancer	0.00426	0.00546	CcSEcCtD
Morphine—Syncope—Octreotide—thymus cancer	0.00425	0.00545	CcSEcCtD
Morphine—Palpitations—Octreotide—thymus cancer	0.00419	0.00537	CcSEcCtD
Morphine—Loss of consciousness—Octreotide—thymus cancer	0.00417	0.00534	CcSEcCtD
Morphine—Cough—Octreotide—thymus cancer	0.00414	0.00531	CcSEcCtD
Morphine—Convulsion—Octreotide—thymus cancer	0.00411	0.00527	CcSEcCtD
Morphine—Hypertension—Octreotide—thymus cancer	0.00409	0.00525	CcSEcCtD
Morphine—Arthralgia—Octreotide—thymus cancer	0.00403	0.00518	CcSEcCtD
Morphine—Chest pain—Octreotide—thymus cancer	0.00403	0.00518	CcSEcCtD
Morphine—Anxiety—Octreotide—thymus cancer	0.00402	0.00516	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00401	0.00514	CcSEcCtD
Morphine—Discomfort—Octreotide—thymus cancer	0.00399	0.00512	CcSEcCtD
Morphine—Dry mouth—Octreotide—thymus cancer	0.00395	0.00506	CcSEcCtD
Morphine—Oedema—Octreotide—thymus cancer	0.00387	0.00496	CcSEcCtD
Morphine—Anaphylactic shock—Octreotide—thymus cancer	0.00387	0.00496	CcSEcCtD
Morphine—Infection—Octreotide—thymus cancer	0.00384	0.00493	CcSEcCtD
Morphine—Shock—Octreotide—thymus cancer	0.00381	0.00488	CcSEcCtD
Morphine—Nervous system disorder—Octreotide—thymus cancer	0.00379	0.00487	CcSEcCtD
Morphine—Thrombocytopenia—Octreotide—thymus cancer	0.00379	0.00486	CcSEcCtD
Morphine—Tachycardia—Octreotide—thymus cancer	0.00377	0.00484	CcSEcCtD
Morphine—Skin disorder—Octreotide—thymus cancer	0.00376	0.00482	CcSEcCtD
Morphine—Hyperhidrosis—Octreotide—thymus cancer	0.00374	0.0048	CcSEcCtD
Morphine—Anorexia—Octreotide—thymus cancer	0.00369	0.00473	CcSEcCtD
Morphine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00352	0.00452	CcSEcCtD
Morphine—Insomnia—Octreotide—thymus cancer	0.0035	0.00449	CcSEcCtD
Morphine—Paraesthesia—Octreotide—thymus cancer	0.00347	0.00446	CcSEcCtD
Morphine—Dyspnoea—Octreotide—thymus cancer	0.00345	0.00442	CcSEcCtD
Morphine—Somnolence—Octreotide—thymus cancer	0.00344	0.00441	CcSEcCtD
Morphine—Dyspepsia—Octreotide—thymus cancer	0.0034	0.00437	CcSEcCtD
Morphine—Decreased appetite—Octreotide—thymus cancer	0.00336	0.00431	CcSEcCtD
Morphine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00334	0.00428	CcSEcCtD
Morphine—Fatigue—Octreotide—thymus cancer	0.00333	0.00428	CcSEcCtD
Morphine—Pain—Octreotide—thymus cancer	0.00331	0.00424	CcSEcCtD
Morphine—Constipation—Octreotide—thymus cancer	0.00331	0.00424	CcSEcCtD
Morphine—Feeling abnormal—Octreotide—thymus cancer	0.00319	0.00409	CcSEcCtD
Morphine—CYP2C8—pituitary gland—thymus cancer	0.00318	0.0144	CbGeAlD
Morphine—Gastrointestinal pain—Octreotide—thymus cancer	0.00316	0.00406	CcSEcCtD
Morphine—Urticaria—Octreotide—thymus cancer	0.00307	0.00394	CcSEcCtD
Morphine—Body temperature increased—Octreotide—thymus cancer	0.00306	0.00392	CcSEcCtD
Morphine—Abdominal pain—Octreotide—thymus cancer	0.00306	0.00392	CcSEcCtD
Morphine—CYP3A4—hematopoietic system—thymus cancer	0.0029	0.0132	CbGeAlD
Morphine—CYP2D6—hematopoietic system—thymus cancer	0.00286	0.0129	CbGeAlD
Morphine—Hypersensitivity—Octreotide—thymus cancer	0.00285	0.00366	CcSEcCtD
Morphine—Asthenia—Octreotide—thymus cancer	0.00277	0.00356	CcSEcCtD
Morphine—Pruritus—Octreotide—thymus cancer	0.00274	0.00351	CcSEcCtD
Morphine—Diarrhoea—Octreotide—thymus cancer	0.00265	0.0034	CcSEcCtD
Morphine—Dizziness—Octreotide—thymus cancer	0.00256	0.00328	CcSEcCtD
Morphine—Vomiting—Octreotide—thymus cancer	0.00246	0.00316	CcSEcCtD
Morphine—Rash—Octreotide—thymus cancer	0.00244	0.00313	CcSEcCtD
Morphine—Dermatitis—Octreotide—thymus cancer	0.00244	0.00313	CcSEcCtD
Morphine—Headache—Octreotide—thymus cancer	0.00242	0.00311	CcSEcCtD
Morphine—Nausea—Octreotide—thymus cancer	0.0023	0.00295	CcSEcCtD
Morphine—ABCB1—hematopoietic system—thymus cancer	0.00206	0.00931	CbGeAlD
Morphine—ABCB1—epithelium—thymus cancer	0.00188	0.00851	CbGeAlD
Morphine—ABCB1—pituitary gland—thymus cancer	0.00152	0.00691	CbGeAlD
Morphine—ABCB1—lymphoid tissue—thymus cancer	0.00145	0.00656	CbGeAlD
Morphine—ABCB1—bone marrow—thymus cancer	0.00132	0.00597	CbGeAlD
Morphine—ABCB1—thyroid gland—thymus cancer	0.00131	0.00596	CbGeAlD
Morphine—ABCB1—lung—thymus cancer	0.00119	0.00541	CbGeAlD
Morphine—ABCB1—lymph node—thymus cancer	0.000817	0.0037	CbGeAlD
